PBT 0.00% 0.0¢ prana biotechnology limited

This is an open access review paper ( Aug, 2018) about different...

  1. 1,078 Posts.
    lightbulb Created with Sketch. 160
    This is an open access review paper ( Aug, 2018) about different tauopathies, that includes Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), Parkinson’s disease (PD), Huntington’s disease (HD), Pick’s disease (PiD) and frontotemporal dementia with parkinsonism. Dr Adlard is shareholder in Prana. A very good review IMO and relates to PBT434.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108061/

 
watchlist Created with Sketch. Add PBT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.